辛靜玫 (2010)。桂花、菊花與芝麻素對肝細胞脂質堆積、發炎與倉鼠脂肪肝之 影響。國立臺灣師範大學人類發展與家庭學系營養科學與教育組碩士論文。
林景正與賴宏仁 (1999)。奈米材料技術與發展趨勢。工業材料，153，95-101。
高秋華 (2008)。數種植物性雌激素對代謝症候群的影響。國立臺灣師範大學人
Abboud, H. E. (1991). Resident glomerular cells in glomerular injury: mesangial cells.
Semin Nephrol, 11(3), 304-311.
Abrass, C. K. (2004). Cellular lipid metabolism and the role of lipids in progressive renal disease. Am J Nephrol, 24(1), 46-53.
Adlercreutz, H. (1990). Western diet and Western diseases: some hormonal and
biochemical mechanisms and associations. Scand J Clin Lab Invest Suppl, 201, 3-23.
Adlercreutz, H. (1999). Phytoestrogens. State of the art. [doi: DOI:
10.1016/S1382-6689(99)00014-9]. Environmental Toxicology and Pharmacology, 7(3), 201-207.
Adlercreutz, H., Hamalainen, E., Gorbach, S., & Goldin, B. (1992). Dietary phyto-oestrogens and the menopause in Japan. Lancet, 339(8803), 1233.
Akiyama, T., Ishida, J., Nakagawa, S., Ogawara, H., Watanabe, S., Itoh, N., et al.
(1987). Genistein, a specific inhibitor of tyrosine-specific protein kinases. J Biol Chem, 262(12), 5592-5595.
Anderson, J. J., Anthony, M., Messina, M., & Garne, S. C. (1999). Effects of phyto-oestrogens on tissues. Nutr Res Rev, 12(1), 75-116.
Atkinson, C., Frankenfeld, C. L., & Lampe, J. W. (2005). Gut bacterial metabolism of the soy isoflavone daidzein: exploring the relevance to human health. Exp Biol Med (Maywood), 230(3), 155-170.
88
Axelson, M., Sjövall, J., Gustafsson, B. E.& Setchell,K. D. R. (1984). Soya:a dietary source of the non-steroidal oestrogen equol in man and animals. Journal of Endocrinology, 102, 49-56.
Banba, N., Nakamura, T., Matsumura, M., Kuroda, H., Hattori, Y., & Kasai, K.
(2000). Possible relationship of monocyte chemoattractant protein-1 with diabetic nephropathy. Kidney Int, 58(2), 684-690.
Bastard, J. P., Maachi, M., Lagathu, C., Kim, M. J., Caron, M., Vidal, H., et al. (2006).
Recent advances in the relationship between obesity, inflammation, and insulin resistance. Eur Cytokine Netw, 17(1), 4-12.
Bellentani, S., & Marino, M. (2009). Epidemiology and natural history of
non-alcoholic fatty liver disease (NAFLD). Ann Hepatol, 8 Suppl 1, S4-8.
Bengtsson, G., & Olivecrona, T. (1980). The hepatic heparin releasable lipase binds to high density lipoproteins. FEBS Lett, 119(2), 290-292.
Boersma, B. J., Barnes, S., Kirk, M., Wang, C. C., Smith, M., Kim, H., et al. (2001).
Soy isoflavonoids and cancer -- metabolism at the target site. [doi: DOI:
10.1016/S0027-5107(01)00175-0]. Mutation Research/Fundamental and Molecular Mechanisms of Mutagenesis, 480-481, 121-127.
Borradaile, N. M., de Dreu, L. E., Wilcox, L. J., Edwards, J. Y., & Huff, M. W.
(2002). Soya phytoestrogens, genistein and daidzein, decrease apolipoprotein B secretion from HepG2 cells through multiple mechanisms. Biochem J, 366(Pt 2), 531-539.
Brown, M. S., & Goldstein, J. L. (1997). The SREBP pathway: regulation of cholesterol metabolism by proteolysis of a membrane-bound transcription factor. Cell, 89(3), 331-340.
Brunt, E. M., & Tiniakos, D. G. (2002). Pathology of steatohepatitis. [doi: DOI:
10.1053/bega.2002.0326]. Best Practice & Research Clinical Gastroenterology, 16(5), 691-707.
Bugianesi, E., McCullough, A. J., & Marchesini, G. (2005). Insulin resistance: a metabolic pathway to chronic liver disease. Hepatology, 42(5), 987-1000.
Carr, M. C. (2003). The emergence of the metabolic syndrome with menopause. J Clin Endocrinol Metab, 88(6), 2404-2411.
Cassidy, A. (1996). Physiological effects of phyto-oestrogens in relation to cancer and other human health risks. Proc Nutr Soc, 55(1B), 399-417.
Chen, C. H., Huang, M. H., Yang, J. C., Nien, C. K., Yang, C. C., Yeh, Y. H., et al.
(2006). Prevalence and risk factors of nonalcoholic fatty liver disease in an adult population of taiwan: metabolic significance of nonalcoholic fatty liver disease in nonobese adults. J Clin Gastroenterol, 40(8), 745-752.
Chen, X. L., Tummala, P. E., Olbrych, M. T., Alexander, R. W., & Medford, R. M.
89
(1998). Angiotensin II induces monocyte chemoattractant protein-1 gene expression in rat vascular smooth muscle cells. Circ Res, 83(9), 952-959.
Cheng, S. Y., Shaw, N. S., Tsai, K. S., & Chen, C. Y. (2004). The hypoglycemic effects of soy isoflavones on postmenopausal women. J Womens Health (Larchmt), 13(10), 1080-1086.
Choi, J. S., & Song, J. (2009). Effect of genistein on insulin resistance, renal lipid metabolism, and antioxidative activities in ovariectomized rats. Nutrition, 25(6), 676-685.
Choi, J. S., & Song, J. (2009). Effect of genistein on insulin resistance, renal lipid metabolism, and antioxidative activities in ovariectomized rats. Nutrition, 25(6), 676-685.
Clarkson, T. B. (2000). Soy phytoestrogens: what will be their role in postmenopausal hormone replacement therapy? Menopause, 7(2), 71-75.
Cortez-Pinto, H., Camilo, M. E., Baptista, A., De Oliveira, A. G., & De Moura, M. C.
(1999). Non-alcoholic fatty liver: another feature of the metabolic syndrome?
Clin Nutr, 18(6), 353-358.
Cousin, S. P., Hugl, S. R., Wrede, C. E., Kajio, H., Myers, M. G., Jr., & Rhodes, C. J.
(2001). Free fatty acid-induced inhibition of glucose and insulin-like growth factor I-induced deoxyribonucleic acid synthesis in the pancreatic beta-cell line INS-1. Endocrinology, 142(1), 229-240.
Dallongeville, J., Marecaux, N., Isorez, D., Zylbergberg, G., Fruchart, J. C., &
Amouyel, P. (1995). Multiple coronary heart disease risk factors are associated with menopause and influenced by substitutive hormonal therapy in a cohort of French women. Atherosclerosis, 118(1), 123-133.
Day, A. J., DuPont, M. S., Ridley, S., Rhodes, M., Rhodes, M. J. C., Morgan, M. R.
A., et al. (1998). Deglycosylation of flavonoid and isoflavonoid glycosides by human small intestine and liver [beta]-glucosidase activity. [doi: DOI:
10.1016/S0014-5793(98)01101-6]. FEBS Letters, 436(1), 71-75.
Day, C. P., & James, O. F. (1998). Steatohepatitis: a tale of two "hits"?
Gastroenterology, 114(4), 842-845.
de Kleijn, M. J., van der Schouw, Y. T., Wilson, P. W., Grobbee, D. E., & Jacques, P.
F. (2002). Dietary intake of phytoestrogens is associated with a favorable metabolic cardiovascular risk profile in postmenopausal U.S.women: the Framingham study. J Nutr, 132(2), 276-282.
de Luca, C., & Olefsky, J. M. (2008). Inflammation and insulin resistance. [doi: DOI:
10.1016/j.febslet.2007.11.057]. FEBS Letters, 582(1), 97-105.
Decroos, K., Vanhemmens, S., Cattoir, S., Boon, N., & Verstraete, W. (2005).
Isolation and characterisation of an equol-producing mixed microbial culture
90
from a human faecal sample and its activity under gastrointestinal conditions.
Arch Microbiol, 183(1), 45-55.
Despres, J. P., Lemieux, I., Bergeron, J., Pibarot, P., Mathieu, P., Larose, E., et al.
(2008). Abdominal obesity and the metabolic syndrome: contribution to global cardiometabolic risk. Arterioscler Thromb Vasc Biol, 28(6), 1039-1049.
Desvergne, B., & Wahli, W. (1999). Peroxisome proliferator-activated receptors:
nuclear control of metabolism. Endocr Rev, 20(5), 649-688.
Dominguez, H., Storgaard, H., Rask-Madsen, C., Steffen Hermann, T., Ihlemann, N., Baunbjerg Nielsen, D., et al. (2005). Metabolic and vascular effects of tumor necrosis factor-alpha blockade with etanercept in obese patients with type 2 diabetes. J Vasc Res, 42(6), 517-525.
Duncan, A. M., Merz, B. E., Xu, X., Nagel, T. C., Phipps, W. R., & Kurzer, M. S.
(1999). Soy isoflavones exert modest hormonal effects in premenopausal women. J Clin Endocrinol Metab, 84(1), 192-197.
Enmark, E., & Gustafsson, J. A. (1999). Oestrogen receptors - an overview. J Intern Med, 246(2), 133-138.
Erdman, J. W., Jr. (2000). Soy Protein and Cardiovascular Disease : A Statement for Healthcare Professionals From the Nutrition Committee of the AHA.
Circulation, 102, 2555-2559.
File, S. E., Jarrett, N., Fluck, E., Duffy, R., Casey, K., & Wiseman, H. (2001). Eating soya improves human memory. Psychopharmacology (Berl), 157(4), 430-436.
Frankenfeld, C. L., Patterson, R. E., Horner, N. K., Neuhouser, M. L., Skor, H. E., Kalhorn, T. F., et al. (2003). Validation of a soy food-frequency questionnaire and evaluation of correlates of plasma isoflavone concentrations in
postmenopausal women. Am J Clin Nutr, 77(3), 674-680.
Gao, Y. H., & Yamaguchi, M. (2000). Suppressive effect of genistein on rat bone osteoclasts: involvement of protein kinase inhibition and protein tyrosine phosphatase activation. Int J Mol Med, 5(3), 261-267.
Geola, F. L., Frumar, A. M., Tataryn, I. V., Lu, K. H., Hershman, J. M., Eggena, P., et al. (1980). Biological effects of various doses of conjugated equine estrogens in postmenopausal women. J Clin Endocrinol Metab, 51(3), 620-625.
Gimenez, I., Lou, M., Vargas, F., Alvarez-Guerra, M., Mayoral, J. A., Martinez, R.
M., et al. (1997). Renal and vascular actions of equol in the rat. J Hypertens, 15(11), 1303-1308.
Goodman-Gruen, D., & Kritz-Silverstein, D. (2001). Usual dietary isoflavone intake is associated with cardiovascular disease risk factors in postmenopausal women. J Nutr, 131(4), 1202-1206.
Gottstein, N., Ewins, B. A., Eccleston, C., Hubbard, G. P., Kavanagh, I. C., Minihane,
91
A. M., et al. (2003). Effect of genistein and daidzein on platelet aggregation and monocyte and endothelial function. Br J Nutr, 89(5), 607-616.
Grone, E. F., Abboud, H. E., Hohne, M., Walli, A. K., Grone, H. J., Stuker, D., et al.
(1992). Actions of lipoproteins in cultured human mesangial cells: modulation by mitogenic vasoconstrictors. Am J Physiol, 263(4 Pt 2), F686-696.
Grone, H. J., Walli, A., Grone, E., Niedmann, P., Thiery, J., Seidel, D., et al. (1989).
Induction of glomerulosclerosis by dietary lipids. A functional and morphologic study in the rat. Lab Invest, 60(3), 433-446.
Hall, W. L., Vafeiadou, K., Hallund, J., Bugel, S., Reimann, M., Koebnick, C., et al.
(2006). Soy-isoflavone-enriched foods and markers of lipid and glucose metabolism in postmenopausal women: interactions with genotype and equol production. Am J Clin Nutr, 83(3), 592-600.
Han, K. K., Soares, J. M., Haidar, M. A., Rodrigues de Lima, G., & Baracat, E. C.
(2002). Benefits of soy isoflavone therapeutic regimen on menopausal symptoms. [doi: DOI: 10.1016/S0029-7844(01)01744-6]. Obstetrics &
Gynecology, 99(3), 389-394.
Hanson, L. N., Engelman, H. M., Alekel, D. L., Schalinske, K. L., Kohut, M. L., &
Reddy, M. B. (2006). Effects of soy isoflavones and phytate on homocysteine, C-reactive protein, and iron status in postmenopausal women. Am J Clin Nutr, 84(4), 774-780.
Harper, A., Kerr, D. J., Gescher, A., & Chipman, J. K. (1999). Antioxidant effects of isoflavonoids and lignans, and protection against DNA oxidation. Free Radic Res, 31(2), 149-160.
Hendrich, S. (2002). Bioavailability of isoflavones. [doi: DOI:
10.1016/S1570-0232(02)00347-1]. Journal of Chromatography B, 777(1-2), 203-210.
Hernandez, C. J., Beaupre, G. S., & Carter, D. R. (2003). A theoretical analysis of the relative influences of peak BMD, age-related bone loss and menopause on the development of osteoporosis. Osteoporos Int, 14(10), 843-847.
Hillyer, J. F., & Albrecht, R. M. (2001). Gastrointestinal persorption and tissue distribution of differently sized colloidal gold nanoparticles. J Pharm Sci, 90(12), 1927-1936.
Hirakata, M., Kaname, S., Chung, U. G., Joki, N., Hori, Y., Noda, M., et al. (1997).
Tyrosine kinase dependent expression of TGF-beta induced by stretch in mesangial cells. Kidney Int, 51(4), 1028-1036.
Ho, S. C., Chan, S. G., Yip, Y. B., Cheng, A., Yi, Q., & Chan, C. (1999). Menopausal symptoms and symptom clustering in Chinese women. Maturitas, 33(3), 219-227.
92
Horton, J. D., Shimomura, I., Brown, M. S., Hammer, R. E., Goldstein, J. L., &
Shimano, H. (1998). Activation of cholesterol synthesis in preference to fatty acid synthesis in liver and adipose tissue of transgenic mice overproducing sterol regulatory element-binding protein-2. J Clin Invest, 101(11), 2331-2339.
Howes, L. G., Howes, J. B., & Knight, D. C. (2006). Isoflavone therapy for menopausal flushes: A systematic review and meta-analysis. [doi: DOI:
10.1016/j.maturitas.2006.03.008]. Maturitas, 55(3), 203-211.
Hsu, C. S., Shen, W. W., Hsueh, Y. M., & Yeh, S. L. (2001). Soy isoflavone supplementation in postmenopausal women. Effects on plasma lipids, antioxidant enzyme activities and bone density. J Reprod Med, 46(3), 221-226.
Hu, B., Pan, C., Sun, Y., Hou, Z., Ye, H., & Zeng, X. (2008). Optimization of
fabrication parameters to produce chitosan-tripolyphosphate nanoparticles for delivery of tea catechins. J Agric Food Chem, 56(16), 7451-7458.
Hu, E., & Shaw, D. (1999). Ch2. Synthesis and Assembly. Nanostructure Science and Technology, 16.
Hur, H. G., Lay, J. O., Jr., Beger, R. D., Freeman, J. P., & Rafii, F. (2000). Isolation of human intestinal bacteria metabolizing the natural isoflavone glycosides daidzin and genistin. Arch Microbiol, 174(6), 422-428.
Hutchins, A. M., Slavin, J. L., & Lampe, J. W. (1995). Urinary isoflavonoid phytoestrogen and lignan excretion after consumption of fermented and unfermented soy products. J Am Diet Assoc, 95(5), 545-551.
Javitt, N. B. (1990). Hep G2 cells as a resource for metabolic studies: lipoprotein, cholesterol, and bile acids. FASEB J, 4(2), 161-168.
Jenkins, D. J., Kendall, C. W., Jackson, C. J., Connelly, P. W., Parker, T., Faulkner, D., et al. (2002). Effects of high- and low-isoflavone soyfoods on blood lipids, oxidized LDL, homocysteine, and blood pressure in hyperlipidemic men and women. Am J Clin Nutr, 76(2), 365-372.
Jiang, T., Wang, Z., Proctor, G., Moskowitz, S., Liebman, S. E., Rogers, T., et al.
(2005). Diet-induced obesity in C57BL/6J mice causes increased renal lipid accumulation and glomerulosclerosis via a sterol regulatory element-binding protein-1c-dependent pathway. J Biol Chem, 280(37), 32317-32325.
Jin, Z., & MacDonald, R. S. (2002). Soy isoflavones increase latency of spontaneous mammary tumors in mice. J Nutr, 132(10), 3186-3190.
Kamanna, V. S., Pai, R., Ha, H., Kirschenbaum, M. A., & Roh, D. D. (1999).
Oxidized low-density lipoprotein stimulates monocyte adhesion to glomerular endothelial cells. Kidney Int, 55(6), 2192-2202.
Kamei, N., Tobe, K., Suzuki, R., Ohsugi, M., Watanabe, T., Kubota, N., et al. (2006).
93
Overexpression of monocyte chemoattractant protein-1 in adipose tissues causes macrophage recruitment and insulin resistance. J Biol Chem, 281(36), 26602-26614.
Kanamori, H., Matsubara, T., Mima, A., Sumi, E., Nagai, K., Takahashi, T., et al.
(2007). Inhibition of MCP-1/CCR2 pathway ameliorates the development of diabetic nephropathy. Biochemical and Biophysical Research Communications, 360(4), 772-777.
Kanno, S., Hirano, S., & Kayama, F. (2004). Effects of phytoestrogens and
environmental estrogens on osteoblastic differentiation in MC3T3-E1 cells.
[doi: DOI: 10.1016/j.tox.2003.12.002]. Toxicology, 196(1-2), 137-145.
Kano, M., Takayanagi, T., Harada, K., Sawada, S., & Ishikawa, F. (2006).
Bioavailability of isoflavones after ingestion of soy beverages in healthy adults. J Nutr, 136(9), 2291-2296.
Kato, H., Osajima, A., Uezono, Y., Okazaki, M., Tsuda, Y., Tanaka, H., et al. (1999).
Involvement of PDGF in pressure-induced mesangial cell proliferation through PKC and tyrosine kinase pathways. Am J Physiol, 277(1 Pt 2), F105-112.
Kershaw, E. E., & Flier, J. S. (2004). Adipose tissue as an endocrine organ. J Clin Endocrinol Metab, 89(6), 2548-2556.
Kim, S., Shin, H. J., Kim, S. Y., Kim, J. H., Lee, Y. S., Kim, D. H., et al. (2004).
Genistein enhances expression of genes involved in fatty acid catabolism through activation of PPARalpha. Mol Cell Endocrinol, 220(1-2), 51-58.
Klahr, S., & Morrissey, J. (2003). Progression of chronic renal disease. Am J Kidney Dis, 41(3 Suppl 1), S3-7.
Klein, E. A. (2005). Chemoprevention of prostate cancer. [doi: DOI:
10.1016/j.critrevonc.2004.11.008]. Critical Reviews in Oncology/Hematology, 54(1), 1-10.
Knight, S. F., & Imig, J. D. (2007). Obesity, insulin resistance, and renal function.
Microcirculation, 14(4-5), 349-362.
Krapp, A., Ahle, S., Kersting, S., Hua, Y., Kneser, K., Nielsen, M., et al. (1996).
Hepatic lipase mediates the uptake of chylomicrons and beta-VLDL into cells via the LDL receptor-related protein (LRP). J Lipid Res, 37(5), 926-936.
Krotkiewski, M., Bjorntorp, P., Sjostrom, L., & Smith, U. (1983). Impact of obesity on metabolism in men and women. Importance of regional adipose tissue distribution. J Clin Invest, 72(3), 1150-1162.
Kuiper, G. G., Lemmen, J. G., Carlsson, B., Corton, J. C., Safe, S. H., van der Saag, P.
T., et al. (1998). Interaction of estrogenic chemicals and phytoestrogens with estrogen receptor beta. Endocrinology, 139(10), 4252-4263.
94
Lampe, J. W., Skor, H. E., Li, S., Wahala, K., Howald, W. N., & Chen, C. (2001).
Wheat bran and soy protein feeding do not alter urinary excretion of the isoflavan equol in premenopausal women. J Nutr, 131(3), 740-744.
Larkin, T., Price, W. E., & Astheimer, L. (2008). The key importance of soy
isoflavone bioavailability to understanding health benefits. Crit Rev Food Sci Nutr, 48(6), 538-552.
Lee, F. T., Cao, Z., Long, D. M., Panagiotopoulos, S., Jerums, G., Cooper, M. E., et al.
(2004). Interactions between angiotensin II and NF-kappaB-dependent pathways in modulating macrophage infiltration in experimental diabetic nephropathy. J Am Soc Nephrol, 15(8), 2139-2151.
Legette, L. L., Martin, B. R., Shahnazari, M., Lee, W. H., Helferich, W. G., Qian, J., et al. (2009). Supplemental dietary racemic equol has modest benefits to bone but has mild uterotropic activity in ovariectomized rats. J Nutr, 139(10), 1908-1913.
Li, Z., McNamara, J. R., Fruchart, J. C., Luc, G., Bard, J. M., Ordovas, J. M., et al.
(1996). Effects of gender and menopausal status on plasma lipoprotein subspecies and particle sizes. J Lipid Res, 37(9), 1886-1896.
Lichtenstein, A. H. (1998). Soy protein, isoflavones and cardiovascular disease risk.
The journal of nutrition, 128(10), 1589-1592.
Lin, C. L., Huang, H. C., & Lin, J. K. (2007). Theaflavins attenuate hepatic lipid accumulation through activating AMPK in human HepG2 cells. J Lipid Res, 48(11), 2334-2343.
Lindoff, C., Petersson, F., Lecander, I., Martinsson, G., & Astedt, B. (1993). Passage of the menopause is followed by haemostatic changes. Maturitas, 17(1), 17-22.
Liu, J.-R., & Lin, C.-W. (2000). Production of Kefir from Soymilk With or Without Added Glucose, Lactose, or Sucrose. Journal of Food Science, 65(4), 716-719.
Liu, R. H. (2004). Potential synergy of phytochemicals in cancer prevention:
mechanism of action. J Nutr, 134(12 Suppl), 3479S-3485S.
Lobo, R. A. (1989). Cardiovascular disease, menopause, and the influence of hormone replacement therapy. Prog Clin Biol Res, 320, 313-332.
Lobo, R. A. (2008). Metabolic syndrome after menopause and the role of hormones.
Maturitas, 60(1), 10-18.
Loukovaara, M., Carson, M., Palotie, A., & Adlercreutz, H. (1995). Regulation of sex hormone-binding globulin production by isoflavonoids and patterns of
isoflavonoid conjugation in HepG2 cell cultures. Steroids, 60(9), 656-661.
Ma, D.-F., Qin, L.-Q., Wang, P.-Y., & Katoh, R. (2008). Soy isoflavone intake increases bone mineral density in the spine of menopausal women:
95
Meta-analysis of randomized controlled trials. [doi: DOI:
10.1016/j.clnu.2007.10.012]. Clinical Nutrition, 27(1), 57-64.
Maas, A. H., & Franke, H. R. (2009). Women's health in menopause with a focus on hypertension. Neth Heart J, 17(2), 68-72.
Maubach, J., Bracke, M. E., Heyerick, A., Depypere, H. T., Serreyn, R. F., Mareel, M.
M., et al. (2003). Quantitation of soy-derived phytoestrogens in human breast tissue and biological fluids by high-performance liquid chromatography. J Chromatogr B Analyt Technol Biomed Life Sci, 784(1), 137-144.
McClements, D. J., Decker, E. A., & Weiss, J. (2007). Emulsion-based delivery systems for lipophilic bioactive components. J Food Sci, 72(8), R109-124.
Mendel, C. M. (1992). The free hormone hypothesis. Distinction from the free hormone transport hypothesis. J Androl, 13(2), 107-116.
Mitchell, J. H., Gardner, P. T., McPhail, D. B., Morrice, P. C., Collins, A. R., &
Duthie, G. G. (1998). Antioxidant Efficacy of Phytoestrogens in Chemical and Biological Model Systems. [doi: DOI: 10.1006/abbi.1998.0951]. Archives of Biochemistry and Biophysics, 360(1), 142-148.
Moorhead, J. F., El-Nahas, M., Chan, M. K., & Varghese, Z. (1982). LIPID
NEPHROTOXICITY IN CHRONIC PROGRESSIVE GLOMERULAR AND TUBULO-INTERSTITIAL DISEASE. The Lancet, 320(8311), 1309-1311.
Moraru, C. I., Panchapakesan, C. P., Huang, Q., Takhistov, P., Liu, S., & Kokini, J. L.
(2003). Nanotechnology: a new frontier in food science. Food Technology, 57(12), 24-29.
Mousavi, Y., & Adlercreutz, H. (1993). Genistein is an effective stimulator of sex hormone-binding globulin production in hepatocarcinoma human liver cancer cells and suppresses proliferation of these cells in culture. [doi: DOI:
10.1016/0039-128X(93)90088-5]. Steroids, 58(7), 301-304.
Mozafari, M. R., Flanagan, J., Matia-Merino, L., Awati, A., Omri, A., Suntres, Z. E., et al. (2006). Recent trends in the lipid-based nanoencapsulation of
antioxidants and their role in foods. Journal of the Science of Food and Agriculture, 86, 2038-2045.
Mullen, E., Brown, R. M., Osborne, T. F., & Shay, N. F. (2004). Soy isoflavones affect sterol regulatory element binding proteins (SREBPs) and
SREBP-regulated genes in HepG2 cells. J Nutr, 134(11), 2942-2947.
Muthyala, R. S., Ju, Y. H., Sheng, S., Williams, L. D., Doerge, D. R.,
Katzenellenbogen, B. S., et al. (2004). Equol, a natural estrogenic metabolite from soy isoflavones: convenient preparation and resolution of R- and S-equols and their differing binding and biological activity through estrogen receptors alpha and beta. Bioorg Med Chem, 12(6), 1559-1567.
96
Nachtigall, L. E. (1999). Sex hormone-binding globulin and breast cancer risk. [doi:
DOI: 10.1016/S1068-607X(98)00182-6]. Primary Care Update for OB/GYNS, 6(2), 39-45.
Nahas, E. A., Nahas-Neto, J., Orsatti, F. L., Carvalho, E. P., Oliveira, M. L., & Dias, R. (2007). Efficacy and safety of a soy isoflavone extract in postmenopausal women: a randomized, double-blind, and placebo-controlled study. Maturitas, 58(3), 249-258.
Nehra, V., Angulo, P., Buchman, A. L., & Lindor, K. D. (2001). Nutritional and metabolic considerations in the etiology of nonalcoholic steatohepatitis. Dig Dis Sci, 46(11), 2347-2352.
Neinhuis, C., & Barthlott, W. (1997). Characterization and distribution of
water-repellent, self-cleaning plant surfaces. Annals of Botany, 79, 667-677.
Nurmi, T., Mazur, W., Heinonen, S., Kokkonen, J., & Adlercreutz, H. (2002).
Isoflavone content of the soy based supplements. [doi: DOI:
10.1016/S0731-7085(01)00612-4]. Journal of Pharmaceutical and Biomedical Analysis, 28(1), 1-11.
Okada, M., Matsumori, A., Ono, K., Furukawa, Y., Shioi, T., Iwasaki, A., et al.
(1998). Cyclic stretch upregulates production of interleukin-8 and monocyte chemotactic and activating factor/monocyte chemoattractant protein-1 in human endothelial cells. Arterioscler Thromb Vasc Biol, 18(6), 894-901.
Ostlund, R. E., Jr. (2004). Phytosterols and cholesterol metabolism. Curr Opin Lipidol, 15(1), 37-41.
Owen, A. J., Roach, P. D., & Abbey, M. (2004). Regulation of low-density
lipoprotein receptor activity by estrogens and phytoestrogens in a HepG2 cell model. Ann Nutr Metab, 48(4), 269-275.
Park, Y. W., Zhu, S., Palaniappan, L., Heshka, S., Carnethon, M. R., & Heymsfield, S.
B. (2003). The metabolic syndrome: prevalence and associated risk factor findings in the US population from the Third National Health and Nutrition Examination Survey, 1988-1994. Arch Intern Med, 163(4), 427-436.
Peterson, G., & Barnes, S. (1991). Genistein inhibition of the growth of human breast cancer cells: Independence from estrogen receptors and the multi-drug
resistance gene. [doi: DOI: 10.1016/0006-291X(91)91423-A]. Biochemical and Biophysical Research Communications, 179(1), 661-667.
Pfeilschifter, J., Koditz, R., Pfohl, M., & Schatz, H. (2002). Changes in
proinflammatory cytokine activity after menopause. Endocr Rev, 23(1), 90-119.
Poehlman, E. T., Toth, M. J., Ades, P. A., & Rosen, C. J. (1997).
Menopause-associated changes in plasma lipids, insulin-like growth factor I
97
and blood pressure: a longitudinal study. Eur J Clin Invest, 27(4), 322-326.
Poehlman, E. T., Toth, M. J., & Gardner, A. W. (1995). Changes in energy balance and body composition at menopause: a controlled longitudinal study. Ann Intern Med, 123(9), 673-675.
Postic, C., & Girard, J. (2008). Contribution of de novo fatty acid synthesis to hepatic steatosis and insulin resistance: lessons from genetically engineered mice. J Clin Invest, 118(3), 829-838.
Potter, S. M., Baum, J. A., Teng, H., Stillman, R. J., Shay, N. F., & Erdman, J. W., Jr.
(1998). Soy protein and isoflavones: their effects on blood lipids and bone density in postmenopausal women. Am J Clin Nutr, 68(6 Suppl),
1375S-1379S.
Razay, G., Heaton, K. W., & Bolton, C. H. (1992). Coronary heart disease risk factors in relation to the menopause. Q J Med, 85(307-308), 889-896.
Rector, R. S., Thyfault, J. P., Wei, Y., & Ibdah, J. A. (2008). Non-alcoholic fatty liver disease and the metabolic syndrome: an update. World J Gastroenterol, 14(2), 185-192.
Rivas, M., Garay, R. P., Escanero, J. F., Cia, P., Jr., Cia, P., & Alda, J. O. (2002). Soy milk lowers blood pressure in men and women with mild to moderate essential hypertension. J Nutr, 132(7), 1900-1902.
Romero, A. M., Doval, M. M., Sturla, M. A., & Judis, M. A. (2004). Antioxidant properties of polyphenol-containing extract from soybean fermented with Saccharomyces cerevisiae. European Journal of Lipid Science and Technology, 106(7), 424-431.
Rovin, B. H., & Tan, L. C. (1994). Role of protein kinase pathways in IL-1-induced chemoattractant expression by human mesangial cells. Kidney Int, 46(4), 1059-1068.
Ruan, X. Z., Varghese, Z., & Moorhead, J. F. (2003). Inflammation modifies lipid-mediated renal injury. Nephrol Dial Transplant, 18(1), 27-32.
Ryan-Borchers, T. A., Park, J. S., Chew, B. P., McGuire, M. K., Fournier, L. R., &
Beerman, K. A. (2006). Soy isoflavones modulate immune function in healthy postmenopausal women. Am J Clin Nutr, 83(5), 1118-1125.
Sarkar, F. H., & Li, Y. (2003). Soy isoflavones and cancer prevention. Cancer Invest, 21(5), 744-757.
Sathyamoorthy, N., & Wang, T. T. (1997). Differential effects of dietary
phyto-oestrogens daidzein and equol on human breast cancer MCF-7 cells.
Eur J Cancer, 33(14), 2384-2389.
Scalbert, A., & Williamson, G. (2000). Dietary intake and bioavailability of polyphenols. J Nutr, 130(8S Suppl), 2073S-2085S.
98
Schieber, A., & Carle, R. (2005). Occurrence of carotenoid cis-isomers in food:
Technological, analytical, and nutritional implications. Trends in Food Science
& Technology, 16(9), 416-422.
Setchell, K. D. (1998). Phytoestrogens: the biochemistry, physiology, and
implications for human health of soy isoflavones. Am J Clin Nutr, 68(6 Suppl), 1333S-1346S.
Setchell, K. D., & Cassidy, A. (1999). Dietary isoflavones: biological effects and relevance to human health. J Nutr, 129(3), 758S-767S.
Setchell, K. D., & Cole, S. J. (2006). Method of defining equol-producer status and its frequency among vegetarians. J Nutr, 136(8), 2188-2193.
Shao, S., Duncan, A. M., Yang, R., Marcone, M. F., Rajcan, I., & Tsao, R. (2011).
Systematic evaluation of pre-HPLC sample processing methods on total and individual isoflavones in soybeans and soy products. Food Research
International, 44(8), 2425-2434.
Shin, E. S., Lee, H. H., Cho, S. Y., Park, H. W., Lee, S. J., & Lee, T. R. (2007).
Genistein downregulates SREBP-1 regulated gene expression by inhibiting site-1 protease expression in HepG2 cells. J Nutr, 137(5), 1127-1131.
Shoelson, S. E., Lee, J., & Yuan, M. (2003). Inflammation and the IKK beta/I kappa B/NF-kappa B axis in obesity- and diet-induced insulin resistance. Int J Obes Relat Metab Disord, 27 Suppl 3, S49-52.
Smith, U., Andersson, C. X., Gustafson, B., Hammarstedt, A., Isakson, P., &
Wallerstedt, E. (2007). Adipokines, systemic inflammation and inflamed adipose tissue in obesity and insulin resistance. [doi: DOI:
10.1016/j.ics.2007.03.015]. International Congress Series, 1303, 31-34.
Sowers, M., Zheng, H., Tomey, K., Karvonen-Gutierrez, C., Jannausch, M., Li, X., et al. (2007). Changes in body composition in women over six years at midlife:
ovarian and chronological aging. J Clin Endocrinol Metab, 92(3), 895-901.
Srivastava, S., & Younossi, Z. M. (2005). Morbid obesity, nonalcoholic fatty liver disease, and weight loss surgery. Hepatology, 42(2), 490-492.
Stevenson, J. C., Crook, D., & Godsland, I. F. (1993). Influence of age and
Stevenson, J. C., Crook, D., & Godsland, I. F. (1993). Influence of age and